Related Experiment Videos
Inhibition of murine suppressor T cell development by 2'-deoxyguanosine in vivo
Advances in Experimental Medicine and Biology
|January 1, 1984
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Prognostic value of BRAF and KRAS mutation status in stage II and III microsatellite instable colon cancers.
International journal of cancer·2015
The curious case of the orange coloured tonsils.
International journal of pediatric otorhinolaryngology·2014
The Emergent Architecture of Autonomous Clocks Described by Computational Algorithms of Regulatory Networks.
Advances in experimental medicine and biology·2026
Physical Frameworks and Theories on How Autonomous Biological Oscillators Synchronize.
Advances in experimental medicine and biology·2026
Leveraging Autonomous Biological Oscillators for Directed Evolution of Switchable Proteins.
Advances in experimental medicine and biology·2026
Synthetic Cell-Based Approaches to Dissect Autonomous Cellular Oscillators: Recent Applications on the Cell Cycle.
Advances in experimental medicine and biology·2026
Autonomous Oscillations of NF-κB.
Advances in experimental medicine and biology·2026
An Autonomous Clock that Controls Genetic Information Flow and Cellular Proteostasis.
Advances in experimental medicine and biology·2026
From oncogenesis to approval: the lentiviral gene therapy revolution in Wiskott-Aldrich syndrome.
Regenerative medicine·2026
Primary extranodal marginal zone lymphoma of gastric mucosa-associated lymphoid tissue in children: a case report and review of the literature.
Journal of medical case reports·2026
Beyond MYD88-only testing: MYD88/CD79B profiling improves molecular detection and MCD genotyping in VRL and CNS lymphomas.
Experimental hematology & oncology·2026
Geranylgeranylation is required for B-cell proliferation and plasma cell survival implications for autoimmune therapy.
Cellular & molecular immunology·2026
A microbiota-driven CCL25-CCR9 axis reprograms intestinal ILC2s in the distal small intestine to promote metabolic dysfunction in obesity.
Cellular and molecular gastroenterology and hepatology·2026